585
Views
4
CrossRef citations to date
0
Altmetric
Review Articles

Current trends in chemical modifications of magnetic nanoparticles for targeted drug delivery in cancer chemotherapy

ORCID Icon, ORCID Icon, , , &
Pages 205-224 | Received 06 Nov 2019, Accepted 03 Feb 2020, Published online: 21 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Xiaoqi Qian, Chenmei Xia, Xia Chen, Qianqian Li & Dong Li. (2022) Self-assembled amphiphilic copolymers–doxorubicin conjugated nanoparticles for gastric cancer therapy with low in vivo toxicity and high efficacy. Journal of Biomaterials Science, Polymer Edition 33:17, pages 2202-2219.
Read now
D. Stanicki, T. Vangijzegem, I. Ternad & S. Laurent. (2022) An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery. Expert Opinion on Drug Delivery 19:3, pages 321-335.
Read now
Sreekanth Reddy Obireddy & Wing-Fu Lai. (2022) ROS-Generating Amine-Functionalized Magnetic Nanoparticles Coupled with Carboxymethyl Chitosan for pH-Responsive Release of Doxorubicin. International Journal of Nanomedicine 17, pages 589-601.
Read now
Shu-Jyuan Yang, Chung-Huan Huang, Chung-Hao Wang, Ming-Jium Shieh & Ke-Cheng Chen. (2020) The Synergistic Effect of Hyperthermia and Chemotherapy in Magnetite Nanomedicine-Based Lung Cancer Treatment. International Journal of Nanomedicine 15, pages 10331-10347.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.